Position of the Mexican Society of Cardiology regarding the indication of fibrates. Med Int Méx 2025; 41 (2): 78-120. https://doi.org/10.24245/mim.v41iFebrero.10277 Abel Alberto Pavía López,1 Juan Carlos Garnica Cuéllar,2 Ivette Cruz Bautista,3 Alejo Díaz Aragón,4 Fernando Javier…
Mexican Consensus Delphy for the indication of favipiravir to patients with COVID-19. Med Int Méx 2025; 41 (2): 72-77. https://doi.org/10.24245/mim.v41iFebrero.9181 José Carlos Herrera García,1 Andrea A Colli Domínguez,2 Luz María Galicia Sánchez,3 Jesús J Vázquez…
Clinical use of neurotropic B vitamins in diseases of the peripheral nervous system in Mexico and Central America. Med Int Méx 2022; 38 (4): 887-902. https://doi.org/10.24245/mim.v38i4.5133 Carlos-Alberto Calderón-Ospina,1 Héctor Gonzalo Franco-González,2 Fernando Leal-Martínez,3 Agni Horacio…
Mexican guidelines in the diagnosis and treatment of dyslipidemias and atherosclerosis. Statement of the Mexican Society of Cardiology. Med Int Méx. 2020 mayo-junio;36(3):390-413. https://doi.org/10.24245/mim.v36i3.3671 Abel A Pavía L,1 Carlos Aguilar S2 Comité Ejecutivo:…
Multidisciplinary consensus on diagnosis, pharmacological and non-pharmacological management of osteoarthritis and the role of crystalline glucosamine sulfate of prescription as a new therapeutic option. Med Int Méx. 2020 mayo-junio;36(3):365-389. https://doi.org/10.24245/mim.v36i3.3692 Alejandro Díaz-Borjón,1 Carlos…